Previous Article | Next Article ![]()
Journal of Bacteriology, February 2002, p. 687-694, Vol. 184, No. 3
0021-9193/01/$04.00+0 DOI: 10.1128/JB.184.3.687-694.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Department of Molecular Biology, Biomolecular Engineering Research Institute, Suita, Osaka 565-0874,1 National Institute of Technology and Evaluation, Shibuya, Tokyo 151-0066,2 Laboratory of Marine Microbiology, Division of Applied Bioscience, Graduate School of Agriculture, Kyoto University, Kyoto 606-8502, Japan3
Received 29 May 2001/ Accepted 31 October 2001
|
|
|---|
|
|
|---|
and
(Pol
and Pol
), which are replicative enzymes of genomic DNA, is the most understood function (52). PCNA works as a homotrimer, which forms a doughnut-shaped structure that can encircle double-stranded DNA. PCNA functions by tethering the DNA polymerase on the DNA strand; therefore, it is called a sliding clamp. In the DNA replication process in Eucarya, replication factor C (RFC) is required as a clamp loader to open the PCNA ring and to introduce the DNA strand into the ring efficiently in an ATP-dependent manner. Then the DNA polymerase binds to PCNA to form a holoenzyme capable of processive DNA replication on the DNA strands. Bacteria constitute a different domain of life. However, a common mechanism exists for facilitating processive DNA replication of the genome by the cooperative work of DNA polymerase and its clamp. PCNA shares a similar three-dimensional structure with the ß subunit of Escherichia coli DNA polymerase III (Pol III), although there is little sequence homology between the two proteins (13, 29, 30, 35). The ß subunit works for tethering Pol III core proteins on the DNA strand (26).
Archaea, the third domain of life (56), resemble the Bacteria in cellular ultrastructure. However, the archaeal proteins related to DNA transactions are more similar to those in Eucarya than to those in Bacteria (38). The similarity of archaeal and eukaryotic DNA replication became evident when haloarchaeal growth was found to be inhibited by aphidicolin, a specific inhibitor of the eukaryotic Pol
-like DNA polymerases (12, 46). It was subsequently confirmed that Archaea contain a family B (
-like) DNA polymerase with an amino acid sequence similar to that of the large subunit of eukaryotic DNA replicases
,
, and
(reviewed in reference 40). In addition, after the total genome sequences of several archaeal organisms were determined, it was confirmed that several genes encoding proteins sharing sequence similarities with eukaryotic DNA replication proteins are present in all archaeal genomes (5, 10, 15, 32). Among them, we characterized DNA polymerases (14, 16, 27, 49, 50), PCNA (6, 18, 35), RFC (7, 36, 39), replication protein A (28), and primase (1, 33) from a hyperthermophilic archaeon, Pyrococcus furiosus. While the Euryarchaeota, a subdomain of Archaea, contain one family B DNA polymerase, their relatives in the crenarchaeotic subdomain possess at least two homologs of the family B DNA polymerase (4, 48). A heterodimeric DNA polymerase from the euryarchaeota was found in earlier research (3, 17, 50). This polymerase is composed of a small (DP1) subunit and a large (DP2) subunit and has higher processivity than the family B polymerase in vitro (16, 50). The DP1 subunit has some sequence similarity with the second subunit of eukaryotic Pol
,
, and
(3, 34). On the other hand, DP2, the catalytic subunit, lacks similarity to any other DNA polymerases, and it was named a family D DNA polymerase (5).
Including the archaeal family B and the family D DNA polymerases, in general, all known replicative DNA polymerases require a sliding clamp, the ß subunit for E. coli, gp45 for bacteriophage T4, and PCNA for eucarya and archaea. Interestingly, two PCNA-like proteins were found in the genome of a crenarchaeon, Sulfolobus solfataricus (9). Both of them stimulated the DNA-synthesizing activity of a family B DNA polymerase from S. solfataricus. However, a direct link between these plural PCNAs and the archaeal plural DNA polymerases has yet to be demonstrated. We now describe the cloning and characterization of three PCNA homologs from Aeropyrum pernix and show that these proteins interact with two DNA polymerases (Pol I and Pol II) which were previously identified in this organism (4). The difference of the band mobilities on the sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) between the recombinant and native proteins detected by the Western blot analysis suggests that A. pernix PCNA 2 (ApePCNA2) used in this study may be a truncated form. However, ApePCNA2 affected Pol I and Pol II activities. These interactions augmented DNA synthesis by both DNA polymerases. Our results, showing the distinct features of the aeropyral PCNAs, provide evidence for the existential significance of plural PCNAs in crenarchaeota and contribute to our understanding of the DNA replication system in the domain Archaea.
|
|
|---|
Production and purification of recombinant ApePCNAs. E. coli BL21-CodonPlus(DE3)-RIL (Stratagene) cells harboring the pAP-PCNAs were grown at 37°C in 1 liter of Luria-Bertani medium containing ampicillin (100 µg/ml) and chloramphenicol (20 ng/ml) to an optical density of 0.5 at 600 nm. Isopropyl-ß-D-thiogalactopyranoside (IPTG) was then added to the culture to a final concentration of 1.0 mM, and growth was continued for 5 h. Cells were harvested, suspended in 25 ml of buffer A (50 mM Tris-HCl, pH 8.0; 0.1 mM EDTA; 0.5 mM dithiothreitol; and 10% glycerol), and lysed by sonication. Cell debris was removed by centrifugation at 30,000 x g for 15 min at 4°C. E. coli proteins were removed by heat treatment at 75°C for 15 min. To the supernatant after centrifugation, polyethyleneimine and NaCl were added to final concentrations of 0.2% and 0.5 M, respectively, and the mixture was stirred for 30 min at 4°C. The proteins in the supernatant (30 ml) were precipitated by adding 16.8 g of ammonium sulfate (80% saturation). The precipitates were dissolved in buffer B (50 mM Tris-HCl, pH 8.0; 0.1 mM EDTA; 0.5 mM dithiothreitol; 10% glycerol; and 0.1 M NaCl) and were dialyzed against the same buffer. The dialysates were applied to an anion-exchange column (HiTrap Q, 5 ml; Pharmacia Biotech) fitted to a high-pressure liquid chromatography apparatus (AKTA explorer 10S; Pharmacia Biotech). The chromatography was developed with a 50-ml linear gradient of 0.1 to 1.0 M NaCl in buffer A at a flow rate of 2 ml/min. ApePCNA1 and ApePCNA3 eluted at a salt concentration of 0.4 to 0.6 M. After the anion-exchange chromatography, the fractions containing PCNA proteins were pooled, diluted in buffer A, and applied to an affinity column (HiTrap heparin, 1 ml; Pharmacia Biotech). The chromatography was developed with a 0.1 to 1.0 M NaCl gradient in buffer A at a flow rate of 1 ml/min. ApePCNA1 and ApePCNA3 eluted at a salt concentration range of 0.25 and 0.6 M, respectively. The purified ApePCNA1 and ApePCNA3 proteins were stored at -20°C as 50% glycerol stock solutions after dialysis against buffer A. In the case of ApePCNA2, the supernatant obtained after sonication was not heat treated. Instead, polyethyleneimine and NaCl were added to concentrations of 0.2% and 1.0 M, respectively, and the mixture was stirred for 30 min at 4°C. The protein in the supernatant was applied to a hydrophobic column (HiTrap Phenyl-Sepharose HP, 1 ml; Pharmacia Biotech), and the chromatography was developed with a 20-ml gradient of 1.5 to 0 M NaCl in buffer A at a flow rate of 1 ml/min. All of the eluted fractions were combined, and this pool was applied to an anion-exchange column (HiTrap Q, 5 ml; Pharmacia Biotech), which was developed with a 50-ml linear gradient of 0.1 to 1.0 M NaCl in buffer A at a flow rate of 2 ml/min. The ApePCNA2 protein eluted at a salt concentration range of 0.6 to 0.7 M. After anion-exchange chromatography, the fractions containing PCNA proteins were pooled, diluted in buffer A, and applied to an affinity column (HiTrap heparin, 1 ml; Pharmacia Biotech), and the chromatography was developed with a 0.1 to 1.0 M NaCl gradient in buffer A at a flow rate of 1 ml/min. The ApePCNA2 protein eluted at a salt concentration of 0.3 M. The purified ApePCNA2 protein was stored at -20°C as a 50% glycerol stock solution after dialysis against buffer A.
Purification of recombinant A. pernix Pol I and Pol II. The preparation of the A. pernix Pol I and Pol II proteins was basically performed as described earlier (4) with some modifications. The expression plasmids pAPP1 (for Pol I) and pAPP2 (for Pol II) were used to transform E. coli CodonPlus-RIL (Stratagene) cells. The genes were expressed by incubating the transformed cells in Luria-Bertani broth supplemented with ampicillin (100 µg/ml) and chloramphenicol (20 ng/ml) at 37°C for 5 h. One-liter cultures of cells harboring the pol genes were harvested by centrifugation at 5,000 x g for 20 min. The cell pellets were suspended in 30 ml of buffer A and were lysed by sonication. The lysates were each centrifuged at 30,000 x g for 20 min, and the supernatant from each preparation was heated at 75°C for 15 min followed by recentrifugation. To the supernatant after centrifugation, polyethyleneimine and NaCl were added to concentrations of 0.1% and 0.5 M, respectively, and the mixture was stirred for 30 min at 4°C. The proteins in the supernatant (30 ml) were precipitated by adding 16.8 g of ammonium sulfate (80% saturation). The precipitates were dissolved in buffer B and dialyzed against the same buffer. The dialysate containing Pol I was applied to an anion-exchange column (HiTrap Q, 5 ml; Pharmacia Biotech), and the chromatography was developed with a 50-ml linear gradient of 0.1 to 1.0 M NaCl in buffer A at a flow rate of 2 ml/min. Pol I eluted at a salt concentration range of 0.2 to 0.3 M. After anion-exchange chromatography, the fractions containing the Pol I proteins were pooled, diluted in buffer A, and applied to an affinity column (HiTrap heparin, 1 ml; Pharmacia Biotech), and the chromatography was developed with a 0.1 to 1.0 M NaCl gradient in buffer A at a flow rate of 1 ml/min. Pol I eluted at a salt concentration range of 0.45 to 0.55 M. In the case of Pol II, after ammonium sulfate precipitation, the dialysate containing Pol II was applied to a cation-exchange column (HiTrap SP, 5 ml; Pharmacia Biotech), and the chromatography was developed with a 50-ml linear gradient of 0.1 to 1.0 M NaCl in buffer A at a flow rate of 2 ml/min. Pol II eluted at a salt concentration range of 0.2 to 0.25 M. After cation-exchange chromatography, the fractions containing the Pol II proteins were pooled, diluted in buffer A, and applied to an affinity column (HiTrap heparin, 1 ml; Pharmacia Biotech). The column was developed with a 0.1 to 1.0 M NaCl gradient in buffer A at a flow rate of 1 ml/min. Pol II eluted at a salt concentration range of 0.25 to 0.35 M. The purified Pol I and Pol II proteins were stored at -20°C as 50% glycerol stock solutions after dialysis against buffer A.
N-terminal amino acid sequencing. The purified PCNAs were fractionated by electrophoresis on an SDS-10% polyacrylamide gel, electroblotted onto a polyvinylidene difluoride (PVDF) membrane (Sequi-Blot PVDF, 0.2 µm; Bio-Rad), stained with Coomassie brilliant blue R250 (0.02% in 40% methanol), and destained with 5% methanol. The protein bands were excised and subjected to automated Edman degradation in an Applied Biosystems model 492 protein sequencer.
DNA polymerase nucleotide incorporation assay. The nucleotide incorporation abilities of Pol I and Pol II, in the absence or presence of ApePCNA1, ApePCNA2, or ApePCNA3, were investigated by using two templates: linearized M13 single-stranded DNA (ssDNA) and circular M13 ssDNA (Takara Shuzo). The oligomer, 5'-ATTCGTAATCATGGTCATAGCTGTTTCCTG-3', which is complementary to positions 6204 to 6233 of M13mp18 DNA (57), was annealed to linearized and circular M13 ssDNA. To create the linearized M13 ssDNA, an oligonucleotide, 5'-GCCAAGCTTGCATGCCTGCAGGTCGACTCT-3', complementary to positions 6260 to 6289 (within the multicloning site), was initially annealed to the circular M13 ssDNA to create a double-stranded region containing some restriction enzyme recognition sites. The DNA was then digested overnight with PstI. The product was purified by ethanol precipitation. The assay was carried out as described below. To anneal the primer to the templates, 0.1 µg of M13 ssDNA per test and 1.0 pmol of the primer in DNA polymerase reaction buffer were boiled for 3 min to ensure denaturation. The mixture was then gradually cooled to room temperature, and 0.5 pmol of the respective DNA polymerase was added. Twenty microliters from this mixture was aliquoted into the respective tube containing either PCNA or buffer. The reaction was initiated by adding deoxyribonucleotide triphosphates to a concentration of 0.1 mM, including 227 nM [methyl-3H]TTP (Amersham). Each 25-µl assay mixture contained 20 mM Tris-HCl (pH 8.8), 5.0 mM MgCl2, and 2 mM 2-mercaptoethanol. The reaction was carried out at 70°C for 5 min for Pol I and for 20 min for Pol II. After the reaction, 20 µl of each reaction mixture was spotted onto DE81 filters (Whatman). The filters were washed three times with a 5% Na2HPO4 solution, and the radioactivity incorporated into the DNA strands was counted by a scintillation counter.
Primer extension analysis. The primer elongation abilities of Pol I and Pol II in the absence or presence of ApePCNA1, ApePCNA2, and ApePCNA3 were also investigated by using two templates. 5' 32P-labeled oligomer, 5'-CTGTGTGAAATTGTTATCCGCTCACAATTC-3', complementary to positions 6177 to 6206 of the M13mp18 genome, was annealed to linearized and circular M13 ssDNA. To anneal the primers to the template, 0.1 µg of M13 ssDNA and 1.0 pmol of 32P-labeled primer in DNA polymerase reaction buffer were boiled for 3 min to ensure denaturation. The mixture was then gradually cooled to room temperature, and 0.5 pmol of the respective DNA polymerase was added. Seven microliters from this mixture was aliquoted into the respective tubes containing either PCNA or buffer. The reaction was initiated by adding deoxyribonucleotide triphosphates to a concentration of 0.2 mM. Each 10-µl assay mixture contained 20 mM Tris-HCl (pH 8.8) and 5.0 mM MgCl2. The reaction was carried out at 70°C for 5 min for Pol I and for 20 min for Pol II. After the reaction, 3 µl of stop solution (98% deionized formamide, 1 mM EDTA, 0.1% xylene cyanol, and 0.1% bromophenol blue) was added, and 2.6 µl of each reaction was analyzed on a 1.0% alkaline agarose gel in 50 mM sodium sulfate and 1 mM EDTA.
Western blotting. A. pernix K1 cells were cultivated as described earlier (44). Ten grams of bacterial cells was suspended in buffer A. The cells were disrupted by a French press, and the supernatant was recovered by centrifugation for 15 min at 25,000 x g. For immunoblot analysis, SDS-10% polyacrylamide gels were electroblotted onto a PVDF membrane (Bio-Rad). The blots were blocked with 5% (wt/vol) skim milk (Wako) in phosphate-buffered saline (PBS) containing 0.1% (vol/vol) Tween 20 (PBS-T) for 1 h and then were incubated for over 1 h at room temperature with a 1:1,000 dilution of rabbit anti-PCNA (-1, -2, and -3) antiserum in 5% skim milk in PBS-T. Membranes were washed using PBS-T and then were incubated for 1 h at room temperature with a 1:10,000 dilution of horseradish peroxidase-conjugated anti-rabbit immunoglobulin G in 5% skim milk in PBS-T. Membranes were washed using PBS-T, and the secondary antibody was detected with the enhanced chemiluminescence Western blotting analysis system (Amersham Pharmacia Biotech).
Immunoprecipitation of ApePCNAs and immunoblotting. One milligram of total protein was diluted into 250 µl of TBS-T buffer (10 mM Tris-HCl, pH 7.6, 140 mM NaCl, 0.1% Triton X-100) and was incubated with the anti-PCNA antibodies at room temperature for 30 min. Immunocomplexes were collected with protein A-Sepharose (Amersham Pharmacia Biotech) for 30 min at room temperature with mixing. Pellets were washed three times with TBS-T buffer, boiled in SDS sample buffer, and loaded onto SDS-12% polyacrylamide gels. Proteins were transferred to a PVDF membrane and were analyzed by Western blotting as described above.
Chemical cross-linking. Purified ApePCNAs were subjected to a chemical cross-linking experiment, using sulfoethylene glycol-bis (succinimidyl succinate) (sulfo-EGS; Sigma) as described earlier (58). The reaction mixtures (10 µl) contained 5 µg of ApePCNA per ml and 50 µM EGS in 20 mM sodium phosphate (pH 7.0) and 150 mM NaCl. The products were analyzed by Western blotting.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. A sequence comparison of eukaryotic and archaeal PCNAsa
|
![]() View larger version (35K): [in a new window] |
FIG. 1. Purification of recombinant ApePCNA homologs from E. coli cells. All samples of each step were fractionated on SDS-10% polyacrylamide gels, which were stained with Coomassie brilliant blue. The sizes of the molecular mass markers (Protein Marker, Broad Range; New England BioLabs, Inc.) are indicated on the left of each figure. The arrows on the right side of the panels show the obtained proteins. (A) Purification steps of recombinant ApePCNA1. Lanes: M, molecular mass markers; 1, crude cell extract after sonication; 2, supernatant from heat treatment (75°C, 15 min.); 3, supernatant after polyethyleneimine treatment; 4, HiTrap Q fraction; and 5, HiTrap heparin fraction. (B) Purification steps of recombinant ApePCNA2. Lanes: M, molecular mass markers; 1, crude cell extract after sonication; 2, supernatant after polyethyleneimine treatment; 3, HiTrap Phenyl Sepharose HP fraction; 4, HiTrap Q fraction; 5, and HiTrap heparin fraction. (C) Purification steps of recombinant ApePCNA3. All lanes are the same as in the case of ApePCNA1.
|
![]() View larger version (62K): [in a new window] |
FIG. 2. Identification of ApePCNAs in A. pernix cells. (A) Recombinant ApePCNA1 (lane 1, 40 ng) and A. pernix cell extracts (lane 2, 30 µg) were separated by SDS-10% PAGE and then were analyzed by Western blotting with anti-ApePCNA1 antiserum. (B) Recombinant ApePCNA2 (lane 1, 80 ng) and A. pernix cell extracts (lane 2, 30 µg) were analyzed with anti-ApePCNA2 antiserum. (C) Recombinant ApePCNA3 (lane 1, 10 ng) and A. pernix cell extracts (lane 2, 15 µg) were analyzed with anti-ApePCNA3 antiserum.
|
in the presence of PCNA (11, 42). Under physiological conditions, replicative helicases and ssDNA binding protein are likely to prevent or alleviate this condition. This pausing occurred, but to a lesser extent, in the presence of all three ApePCNAs (Fig. 3). The reason why the pauses were weaker in the ApePCNA-DNA polymerase complexes remains unclear at this stage. Further analyses, including measurement of the strength of each PCNA-polymerase interaction and direct loading and unloading assays of these archaeal PCNAs, are necessary to understand the different features of the in vitro reaction products.
![]() View larger version (79K): [in a new window] |
FIG. 3. Detection of the reaction products by Pol I and Pol II. The primer elongation abilities of Pol I and Pol II in the absence and presence (0.3 µg) of ApePCNA1 (lane 1), ApePCNA2 (lane 2), and ApePCNA3 (lane 3) were investigated by using two templates: circular M13 ssDNA (panel A) and linearized M13 ssDNA (panel B). Lanes N and P indicate reactions without PCNA and with PfuPCNA, respectively, in both panels. The products were analyzed by 1.2% alkaline agarose gel electrophoresis, and the reaction products were visualized by autoradiography. The sizes indicated on the right side were from BstPI-digested lambda DNA labeled by polynucleotide kinase with [ -32P]ATP. The arrow shows the position of the product with full-length M13 DNA.
|
![]() View larger version (30K): [in a new window] |
FIG. 4. Association states of ApePCNAs assessed by chemical cross-linking. ApePCNA1 (A), ApePCNA2 (B), and ApePCNA3 (C) were treated with buffer (lane1) and sulfo-EGS (lane 2) for 2 min and were analyzed by SDS-10% PAGE, followed by Western blotting using anti-ApePCNA1, anti-ApePCNA2, and anti-ApePCNA3, respectively. Lanes 3 in panel A and B include equal amounts of ApePCNA1 and ApePCNA2. The cross-linked products from the mixture of ApePCNA1 and ApePCNA2 are indicated by a thick arrow. Each band is derived from a PCNA monomer (a), a single cross-linked dimer (b), three cross-linked circled trimers (c), and two cross-linked linear trimers (d), as indicated for the T4 gp45 protein (19). The indicated molecular sizes were derived from the prestained protein markers (APRO Science, Inc.).
|
![]() View larger version (40K): [in a new window] |
FIG. 5. Analysis of heterologous interactions of ApePCNAs. (A to C) Immunoprecipitation analysis was done using purified ApePCNAs and anti-ApePCNA1 (left part of each panel), anti-ApePCNA2 (middle part), and anti-ApePCNA3 (right part). The immunocomplexes were captured with protein A-Sepharose and were subjected to SDS-12% PAGE, followed by Western blot analysis using anti-PCNA1 (A), anti-PCNA2 (B), and anti-PCNA3 (C). Lanes: N, no protein; 1, ApePCNA1; 2, ApePCNA2; 3, ApePCNA3; 4, ApePCNA1 + ApePCNA2; 5, ApePCNA1 + ApePCNA3; 6, ApePCNA2 + ApePCNA3; and 7, ApePCNA1 + ApePCNA2 + ApePCNA3. (D to F) Total cell extract of A. pernix was reacted with anti-ApePCNA1 (lane C1), anti-ApePCNA2 (lane C2), and anti-ApePCNA3 (lane C3). These complexes were captured with protein A-Sepharose, and the immunoprecipitates were analyzed as described above, using anti-ApePCNA1 (D), anti-ApePCNA2 (E), and anti-ApePCNA3 (F). As a positive control, purified ApePCNAs precipitated by anti-PCNAs were loaded onto each gel (lanes: R1, ApePCNA1; R2, ApePCNA2; and R3, ApePCNA3).
|
|
|
|---|
|
View this table: [in a new window] |
TABLE 2. A sequence comparison of crenarchaeal PCNAs
|
From a study of the DNA polymerase activities of the Pol
catalytic subunit from yeast and human, a consensus motif, GX4GX8GX3YFY, in which the subunit was proposed to be important for binding to PCNA (59), was put forth. The A. pernix Pol II has a sequence resembling this consensus motif in its N-terminal region, while Pol I does not. In several eukaryotic proteins that are known to interact with PCNA, including the cell cycle checkpoint protein p21, and the endonucleases FEN1 and XPG, an octapeptide sequence, referred to as the PCNA-interacting protein box, is conserved (5355). Like the consensus sequence described above, Pol II of A. pernix has a sequence resembling the PCNA-interacting protein motif (QSTLLDFM) in its C-terminal region, while this box is not included in Pol I. Consistent with these results, the A. pernix Pol II has a higher requirement for stimulation by PCNA than does Pol I (Fig. 3). Our previous study showed that Pol I has a much more efficient primer extension ability by itself than Pol II in vitro (4); therefore, it is likely that the actual effect of the PCNAs on Pol I may be much less than that on Pol II, resulting from the weaker interaction. Quantitative analyses are necessary to discuss the strength of each DNA polymerase-PCNA interaction.
As previously found in a P. furiosus study (6), the DNA synthesis reactions by the two A. pernix DNA polymerases were stimulated by the ApePCNAs, even when a circular DNA template was used. It is well known that a molecule called the "clamp loader" (
complexes in Bacteria and RFC in Eucarya) is required for the opening and loading of the ring-shaped sliding clamp onto circular DNA. One possible explanation is that the subunit-subunit interaction of archaeal PCNA from its predicted ring structure may be less stable than those of other sliding clamp molecules, which cause the ring of PCNA to open spontaneously in vitro at a high reaction temperature. In the crystal structures of yeast and human PCNA, a stable interface connection is produced through seven and eight clustered main chain hydrogen bonds, respectively (13, 30). However, there are only four hydrogen bonds between the subunit main chains of PfuPCNA (35). A multiple sequence alignment of the PCNAs showed that there are some deletions in the loop constituting the interfaces of the archaeal PCNAs (Fig. 6). ApePCNA1 and ApePCNA2 have deletions in the first interface region, and ApePCNA3 also has some deletions in the second interface. Due to the weak connections of the subunits, these archaeal PCNAs may be able to load onto the DNA strand without the clamp-loading activity of RFC, which is usually required to load PCNA onto DNA in the eukaryotic system. However, there is a sequence of an RFC homolog in the A. pernix genome. As in the cases of P. furiosus (7) and S. solfataricus (41), the clamp-loading process is possibly much more efficient in the presence of RFC in A. pernix cells. There is only one set of sequences corresponding to the small and large subunits of RFC in A. pernix. The relationship between the RFC and the three PCNAs should be analyzed.
![]() View larger version (67K): [in a new window] |
FIG. 6. Amino acid sequence alignment of the three ApePCNAs, P. furiosus, yeast, and human PCNAs. Identical and similar amino acid residues are boxed with black and gray, respectively. Important regions required for the function and oligomerization of PCNA, predicted from previous studies, are indicated with the alignment. Ape, A. pernix; Pfu, P. furiosus; Sce, Saccharomyces cerevisiae; Hsa, Homo sapiens.
|
. From this analogy, we carefully analyzed whether the three PCNA homologs interact with each other and work as the sliding clamps for Pol I and Pol II. Our results showed that ApePCNA1 and ApePCNA2 may work together, but the heterocomplex is probably not a clamp for either Pol I or Pol II. ApePCNA1 and ApePCNA2 may be a specific clamp for a DNA polymerase with translesion activity, which has not been identified in A. pernix. We searched for a sequence in the A. pernix genome that is similar to the DNA polymerases belonging to the DinB/UmuC/Rev1/Rad30 superfamily (the name of family Y has been recently acknowledged [37] for DNA polymerases in this family), but no distinct similarity was found. However, a gene encoding a sequence homologous to that of DinB protein exists in Sulfolobus (31), and the gene product can bypass an abasic site with its nonprocessive DNA polymerase activity (60). A. pernix may have translesion DNA polymerases with very divergent sequences from those of family Y. Crenarchaeal organisms may have commonly three PCNA-like proteins; therefore, including the subject of the possibility as the sliding clamp for a translesion DNA polymerase, further studies are necessary to explain the biological meaning of the three PCNAs in A. pernix. The information obtained from this study would contribute to a better understanding of the DNA replication mechanism in Crenarchaeota.
|
|
|---|
|
|
|---|
and DNA polymerase
. Mol. Cell. Biol. 17:63676378.[Abstract]
-like DNA polymerase from the hyperthermophilic archaeon Pyrococcus furiosus. Biol. Pharm. Bull. 18:16471652.[Medline]
. Genes Cells 6:699706.[Abstract]
5' exonucleolytic activities in Pyrococcus furiosus DNA polymerase I. Protein Eng. 13:4147.
holoenzyme: action on single-stranded DNA and on double-stranded DNA in the presence of replicative DNA helicases. Biochemistry 34:50035010.[CrossRef][Medline]
-like DNA polymerases. J. Bacteriol. 177:21642177.
is involved in proliferating cell nuclear antigen binding. J. Biol. Chem. 270:79887992.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»